Imipenem cilastatin contraindications: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 4: | Line 4: | ||
==Contraindications== | ==Contraindications== | ||
PRIMAXIN I.V. is contraindicated in patients who have shown hypersensitivity to any component of this product.<ref>{{Cite web | last = | first = |title =http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050587s065,050630s028lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050587s065,050630s028lbl.pdf | publisher =|date = | accessdate = }}</ref> | PRIMAXIN I.V. is contraindicated in patients who have shown [[hypersensitivity]] to any component of this product.<ref>{{Cite web | last = | first = |title =http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050587s065,050630s028lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050587s065,050630s028lbl.pdf | publisher =|date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
Latest revision as of 22:32, 5 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Contraindications
PRIMAXIN I.V. is contraindicated in patients who have shown hypersensitivity to any component of this product.[1]
References
- ↑ "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050587s065,050630s028lbl.pdf" (PDF). External link in
|title=(help)
Adapted from the FDA Package Insert.